Olfr1079 Activators
Olfr1079 Activators encompass a range of chemical compounds that indirectly enhance the functional activity of the olfactory receptor Olfr1079 through the modulation of specific biochemical pathways, primarily centering around the elevation of intracellular cyclic AMP (cAMP) levels. Forskolin, a prominent activator, initiates this enhancement by directly increasing cAMP levels, thereby activating protein kinase A (PKA), a key player in phosphorylating substrates within olfactory signaling pathways. This phosphorylation cascade can influence the sensitivity or response dynamics of Olfr1079. Similarly, IBMX and Theophylline, both phosphodiesterase inhibitors, prevent cAMP degradation, leading to its accumulation and subsequent potentiation of cAMP-dependent signaling pathways integral to Olfr1079 function. This mechanism is echoed in Rolipram, Vardenafil, Zaprinast, and Sildenafil, each contributing to elevated cAMP levels, albeit through different receptor interactions or enzyme inhibitions. Furthermore, Isoproterenol and Epinephrine, through beta-adrenergic receptor activation, and Norepinephrine, through adrenergic receptors, all increase cAMP levels, indirectly amplifying Olfr1079's activity. These compounds, by converging on the cAMP pathway, collectively enhance the functional activity of Olfr1079 in olfactory neurons.
In a complementary manner, Prostaglandin E2 (PGE2) and Adenosine also contribute to this network of Olfr1079 activators. PGE2, by interacting with its receptors, and Adenosine, through A2 receptors, both lead to increased cAMP levels, further potentiating the cAMP-dependent signaling pathways. This intricate network of biochemical interactions and signaling cascades, initiated and modulated by these diverse compounds, underscores the complexity and specificity of Olfr1079 activation. The cumulative effect of these activators is a refined and enhanced response of Olfr1079, illustrating the intricate interplay of biochemical pathways in olfactory receptor function. Each compound, while distinct in its mechanism, contributes to a converging effect: the amplified activity of Olfr1079, thereby underscoring the importance of cAMP and its related signaling pathways in modulating the sensitivity and functionality of olfactory receptors.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX, as a phosphodiesterase inhibitor, prevents cAMP breakdown, leading to its accumulation. Increased cAMP can enhance Olfr1079's activity by potentiating cAMP-dependent signaling pathways in olfactory receptor function. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with adrenergic receptors to increase intracellular cAMP levels, indirectly enhancing Olfr1079's activity by amplifying cAMP-dependent signaling pathways involved in olfactory receptor activation. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Norepinephrine activates adrenergic receptors, increasing cAMP, and indirectly augments Olfr1079's functional activity by enhancing cAMP-dependent signaling in olfactory neurons. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, as a selective phosphodiesterase-4 inhibitor, increases cAMP levels in olfactory sensory neurons, thereby potentially enhancing Olfr1079 activity through elevated cAMP-dependent signaling. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a synthetic sympathomimetic amine, increases cAMP levels via beta-adrenergic receptor activation, potentially enhancing Olfr1079 activity by influencing the cAMP signaling pathway. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 interacts with its receptors, potentially leading to increased cAMP levels, which could enhance Olfr1079's activity by modulating the cAMP signaling pathway involved in olfactory transduction. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine, through its A2 receptors, increases intracellular cAMP levels, potentially enhancing Olfr1079's activity by influencing cAMP-dependent olfactory signaling pathways. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Vardenafil, a phosphodiesterase-5 inhibitor, can increase cAMP levels, potentially enhancing Olfr1079's activity by augmenting the cAMP signaling pathway in olfactory neurons. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast, a phosphodiesterase inhibitor, increases cAMP levels, potentially enhancing Olfr1079 activity through heightened cAMP-dependent signaling in olfactory pathways. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
Theophylline, a phosphodiesterase inhibitor, increases cAMP levels, potentially enhancing Olfr1079's activity by influencing cAMP-dependent signaling pathways in olfactory receptor function. | ||||||